CapitolRadar tracks every publicly disclosed COR trade by US congress members and corporate insiders: 29 disclosed trades (13 buys, 16 sells) by 4 tracked traders, from 2022-02-23 to 2026-09-04. Updated daily from official filings.
Want a ping when Congress buys COR? Free email alerts on notable disclosed trades — plus a $100,000 fantasy portfolio to play along against three AI traders. Join free
Cencora, Inc. (COR) — Healthcare · Medical - Distribution, market cap about $61.6B.
CapitolRadar analysis
29 tracked COR trades: 13 buys and 16 sells
The disclosed activity in Cencora, Inc. (COR), a Healthcare / Medical - Distribution company, covers 29 tracked trades by four distinct traders from February 23, 2022 through September 4, 2026. The total consists of 13 buys and 16 sells, a modest three-trade tilt toward sales. With only four traders represented, this is a small sample and should not be treated as a broad measure of congressional or insider sentiment.
The supplied quarterly detail accounts for 22 of the 29 trades, so it is not a complete quarter-by-quarter chronology. The busiest listed period was 2023 Q1, with seven trades: three buys and four sells. Other listed quarters were smaller, ranging from one to three trades. All three trades in 2024 Q4 were buys, while 2026 Q1 had two buys. In 2026 Q2, the single tracked trade was a sell; 2026 Q3 contained one buy.
8 of 13 buys came from Ro Khanna
Ro Khanna recorded eight COR buys, the largest count among the four identified buyers, with the latest dated September 4, 2026. Jared Moskowitz had two buys, most recently March 31, 2026, and Michael McCaul had two, most recently October 9, 2024. Diana Harshbarger had one buy, dated January 25, 2023. Together, these buyer counts reconcile to all 13 tracked purchases, but the limited number of participants makes individual activity disproportionately influential.
3 COR buyers also bought META
Among the COR buyers, three also bought META. Two apiece also bought AJG, TER, WDAY, MA and HCA. These overlaps identify shared disclosed holdings or purchases only; they do not establish coordination, timing relationships or motives.
Disclosure timing is an important limitation: reported transactions can appear up to 45 days after the trade, so the public record may lag actual activity. Transaction amount ranges, when reported, are estimates rather than exact values; no amount data is supplied here, preventing dollar-volume comparisons.
Analysis written from the tracked record on 2026-10-12; it is refreshed whenever the underlying numbers change.
Activity by quarter
| Quarter | Disclosed trades | Buys | Sells |
|---|---|---|---|
| 2026 Q3 | 1 | 1 | 0 |
| 2026 Q2 | 1 | 0 | 1 |
| 2026 Q1 | 2 | 2 | 0 |
| 2024 Q4 | 3 | 3 | 0 |
| 2024 Q1 | 3 | 1 | 2 |
| 2023 Q3 | 2 | 1 | 1 |
| 2023 Q2 | 3 | 1 | 2 |
| 2023 Q1 | 7 | 3 | 4 |
Who is buying COR?
| Trader | Disclosed buys | Last buy | Grade |
|---|---|---|---|
| Ro Khanna | 8 | 2026-09-04 | — |
| Jared Moskowitz | 2 | 2026-03-31 | — |
| Michael McCaul | 2 | 2024-10-09 | — |
| Diana Harshbarger | 1 | 2023-01-25 | — |
Disclosed trades in COR
| Date | Who | Type | Amount | 30d vs SPY |
|---|---|---|---|---|
| 2026-09-04 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-05-06 | Jared Moskowitz | sell | $1,001 - $15,000 | — |
| 2026-03-31 | Jared Moskowitz | buy | $1,001 - $15,000 | — |
| 2026-03-23 | Jared Moskowitz | buy | $1,001 - $15,000 | — |
| 2024-11-15 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2024-10-09 | Michael McCaul | buy | $15,001 - $50,000 | — |
| 2024-10-09 | Michael McCaul | buy | $50,001 - $100,000 | — |
| 2024-02-20 | Michael McCaul | sell | $1,001 - $15,000 | — |
| 2024-02-20 | Michael McCaul | sell | $50,001 - $100,000 | — |
| 2024-01-10 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-09-06 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2023-08-29 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-06-29 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-05-12 | Michael McCaul | sell | $15,001 - $50,000 | — |
| 2023-05-12 | Michael McCaul | sell | $100,001 - $250,000 | — |
| 2023-03-24 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2023-03-14 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2023-02-10 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-01-25 | Diana Harshbarger | buy | $1,001 - $15,000 | — |
| 2023-01-11 | Ro Khanna | buy | $1,001 - $15,000 | — |
These buyers also bought
Other stocks the tracked buyers of COR disclosed buying in the last six months: META (3) · TER (2) · WDAY (2) · MA (2) · AJG (2) · HCA (2).
About Cencora, Inc.
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare pro…
Frequently asked questions
Which politicians bought COR most?
Ro Khanna leads with 8 disclosed buys, followed by Jared Moskowitz.
How current is this page?
It re-renders from the tracked record on every view and new filings are ingested daily — but STOCK Act disclosures can lag the trade by up to 45 days, so the most recent weeks are always incomplete.
Get alerts when trades like these are disclosed. Free account: fantasy portfolio + email alerts. Premium: a 6-hour head start on every signal.
CapitolRadar tracks publicly disclosed trades (STOCK Act filings and SEC Form 4). Disclosures can lag the trade by up to 45 days. Backtests measure past disclosed buys against the S&P 500 and do not predict future results. Everything on this page is impersonal information for your own research — not investment advice.